Hepatitis C: tackling the silent epidemic

Area of Science:

• Hepatology
• Infectious Diseases
• Public Health

Background:

• Chronic hepatitis C virus (HCV) infection presents a substantial and increasing challenge to National Health Service (NHS) resources.
• HCV is a primary cause of liver cirrhosis and hepatocellular carcinoma (HCC).
• It is the leading reason for liver transplantation.

Purpose of the Study:

• To highlight the significant impact of chronic hepatitis C virus infection on healthcare services.
• To underscore the need for improved detection and treatment access.
• To emphasize the potential of current treatments to manage HCV.

Main Methods:

• Literature review on the epidemiology and clinical impact of chronic hepatitis C.
• Analysis of treatment efficacy and outcomes.
• Assessment of barriers to diagnosis and care.

Main Results:

• Hepatitis C virus infection leads to significant morbidity and mortality, including cirrhosis and liver cancer.
• Current antiviral therapies can achieve viral eradication in over 50% of treated individuals.
• Progress in managing HCV is limited by insufficient case detection and restricted access to available treatments.

Conclusions:

• Effective treatments exist for chronic hepatitis C, offering high cure rates.
• Addressing inadequate detection and improving treatment accessibility are critical to reduce the burden of HCV.
• Further efforts are needed to optimize patient identification and ensure equitable access to care for hepatitis C virus infection.